Expression, purification, and physicochemical characterization of the N-terminal active site of human angiotensin-I converting enzyme
✍ Scribed by Sotirios-Spyridon M. Vamvakas; Leondios Leondiadis; George Pairas; Evy Manessi-Zoupa; Georgios A. Spyroulias; Paul Cordopatis
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 421 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1075-2617
- DOI
- 10.1002/psc.788
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We have cloned, over expressed, and purified one of the two catalytic domains (residues Ala^361^ to Gly^468^, ACE‐N) of human somatic angiotensin‐I converting enzyme in Escherichia coli. This construct represents the N‐catalytic domain including the two binding motifs and the 23 amino acid spacers as well as some amino acid residues before and after the motifs that might help in correct conformation. The overexpressed protein was exclusively localized to insoluble inclusion bodies. Inclusion bodies were solubilized in an 8‐M urea buffer. Purification was carried out by differential centrifugation and gel filtration chromatography under denaturing conditions. About 12 mg of ACE‐N peptide per liter of bacterial culture was obtained. The integrity of recombinant protein domain was confirmed by ESI/MS. Structural analysis using CD spectroscopy has shown that, in the presence of TFE, the ACE‐N protein fragment has taken a conformation, which is consistent with the one found in testis ACE by X‐ray crystallography. This purification procedure enables the production of an isotopically labeled protein fragment for structural studying in solution by NMR spectroscopy. Copyright © 2006 European Peptide Society and John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract A secreted form of phospholipase A~2~ (PLA~2~) is thought to play an important role in inflammatory diseases. To characterize this enzyme the cDNA encoding a low molecular weight PLA~2~ was cloned from a human placental cDNA library. The cDNA encoding the human PLA~2~ was subcloned into
The tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro (AcSDKP) was first isolated from bone marrow extracts and shown to be involved in the negative control of hematopoiesis by preventing the recruitment of primitive stem cells into S-phase. In vitro studies on AcSDKP catabolism in human plasma revealed that Ac